BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 33804735)

  • 1. The PARP Way to Epigenetic Changes.
    Ummarino S; Hausman C; Di Ruscio A
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33804735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of poly(ADP-Ribose) polymerase 1 functions by post-translational modifications.
    Piao L; Fujioka K; Nakakido M; Hamamoto R
    Front Biosci (Landmark Ed); 2018 Jan; 23(1):13-26. PubMed ID: 28930534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Poly(ADP-Ribose) Polymerases 1 and 2: Classical Functions and Interaction with New Histone Poly(ADP-Ribosyl)ation Factor HPF1].
    Kurgina TA; Lavrik OI
    Mol Biol (Mosk); 2023; 57(2):254-268. PubMed ID: 37000654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ; Bourgeois M; Harbison RD
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(ADP-ribose) polymerase-1 affects vasopressin-mediated AQP2 expression in collecting duct cells of the kidney.
    Jang HJ; Park E; Jung HJ; Kwon TH
    Am J Physiol Renal Physiol; 2024 Jan; 326(1):F69-F85. PubMed ID: 37855039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly-ADP ribosylation in DNA damage response and cancer therapy.
    Hou WH; Chen SH; Yu X
    Mutat Res Rev Mutat Res; 2019; 780():82-91. PubMed ID: 31395352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studying PAR-Dependent Chromatin Remodeling to Tackle PARPi Resistance.
    Andronikou C; Rottenberg S
    Trends Mol Med; 2021 Jul; 27(7):630-642. PubMed ID: 34030964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling.
    van Beek L; McClay É; Patel S; Schimpl M; Spagnolo L; Maia de Oliveira T
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34066057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PARP1-modulated chromatin remodeling is a new target for cancer treatment.
    Sinha S; Molla S; Kundu CN
    Med Oncol; 2021 Aug; 38(10):118. PubMed ID: 34432161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serine-linked PARP1 auto-modification controls PARP inhibitor response.
    Prokhorova E; Zobel F; Smith R; Zentout S; Gibbs-Seymour I; Schützenhofer K; Peters A; Groslambert J; Zorzini V; Agnew T; Brognard J; Nielsen ML; Ahel D; Huet S; Suskiewicz MJ; Ahel I
    Nat Commun; 2021 Jul; 12(1):4055. PubMed ID: 34210965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADP-ribosyltransferases and poly ADP-ribosylation.
    Liu C; Yu X
    Curr Protein Pept Sci; 2015; 16(6):491-501. PubMed ID: 25938242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New perspectives on the plant PARP family: Arabidopsis PARP3 is inactive, and PARP1 exhibits predominant poly (ADP-ribose) polymerase activity in response to DNA damage.
    Gu Z; Pan W; Chen W; Lian Q; Wu Q; Lv Z; Cheng X; Ge X
    BMC Plant Biol; 2019 Aug; 19(1):364. PubMed ID: 31426748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(ADP-ribose) Polymerase 1 Modulates Interaction of the Nucleotide Excision Repair Factor XPC-RAD23B with DNA via Poly(ADP-ribosyl)ation.
    Maltseva EA; Rechkunova NI; Sukhanova MV; Lavrik OI
    J Biol Chem; 2015 Sep; 290(36):21811-20. PubMed ID: 26170451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation.
    Suskiewicz MJ; Zobel F; Ogden TEH; Fontana P; Ariza A; Yang JC; Zhu K; Bracken L; Hawthorne WJ; Ahel D; Neuhaus D; Ahel I
    Nature; 2020 Mar; 579(7800):598-602. PubMed ID: 32028527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncovering the Invisible: Mono-ADP-ribosylation Moved into the Spotlight.
    Hopp AK; Hottiger MO
    Cells; 2021 Mar; 10(3):. PubMed ID: 33808662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A PARP1-TIMELESS alliance in cancer therapy.
    Tarsounas M
    Mol Cell; 2024 May; 84(10):1824-1825. PubMed ID: 38759623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MORC2 regulates DNA damage response through a PARP1-dependent pathway.
    Zhang L; Li DQ
    Nucleic Acids Res; 2019 Sep; 47(16):8502-8520. PubMed ID: 31616951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins.
    Alemasova EE; Lavrik OI
    Nucleic Acids Res; 2019 May; 47(8):3811-3827. PubMed ID: 30799503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.
    Hu K; Wu W; Li Y; Lin L; Chen D; Yan H; Xiao X; Chen H; Chen Z; Zhang Y; Xu S; Guo Y; Koeffler HP; Song E; Yin D
    EMBO Rep; 2019 May; 20(5):. PubMed ID: 30940648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Enigmatic Function of PARP1: From PARylation Activity to PAR Readers.
    Kamaletdinova T; Fanaei-Kahrani Z; Wang ZQ
    Cells; 2019 Dec; 8(12):. PubMed ID: 31842403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.